NYU Langone Medical Center to Lead Research to Develop Breath Test for Chronic Obstructive Pulmonary Disease

NYU Langone Medical Center will lead a new clinical initiative -- funded by a $225,000 grant from The National Institutes of Health -- to determine a breath test’s effectiveness to identify volatile organic compounds (VOCs) in human breath that are biomarkers of chronic obstructive pulmonary disease (COPD). The study will employ patented technology developed by Menssana Research, a leading developer of advanced new breath tests for early detection of a wide variety of illnesses and diseases, and the principal recipient of the NIH grant. Read more...


NYU Langone Study Challenges Controversial Blood Pressure Targets for Older Patients

A new study led by Sripal Bangalore, MD, associate professor of Medicine in the Leon H. Charney Division of Cardiology, in the Cardiac and Vascular Institute at NYU Langone Medical Center found that current blood pressure recommendations for people aged 60 years and older who suffer from coronary artery disease (CAD) may not be optimal compared to the previous guidelines. The findings, based on analysis of more than 8,000 patient records, were published in the Journal of the American College of Cardiology (JACC). Read more...